This technology has vast potential to help patients but remains underutilized and underappreciated. The tools are there. What’s lacking are harmonized controls, regulatory guidelines and database ...

America's Growth Leaders Cytek Biosciences has been recognized by TIME as one of America’s Growth Leaders of 2026. Presented in partnership with global data firm Statista, the ranking recognizes the ...

FREMONT, Calif., Oct. 29, 2025 (GLOBE NEWSWIRE) -- Amid the reduction of various government grant programs and global economic challenges that have tightened research funding, Cytek Biosciences, Inc. ...

Tuspetinib Continues to Demonstrate Excellent Safety and Complete Responses in the TUSCANY Clinical Trial of Tuspetinib in AML Triple Drug Frontline Therapy at Increased Dose LevelsPatients are Now ...

The implementation of VCE scoring in clinical practice could inform early pre-emptive therapeutic interventions, exclusively ...

U.S. News compares companies to their industry peers based on a variety of company fundamentals, performance metrics and investor preferences to help you find the right stocks for your investing style ...

Freeze-dried (lyophilized) phycoerythrin leads the market with 64% share in 2025 due to its exceptional stability and long ...

The region has proved unexpectedly resilient, aided by a front-loading of exports, technology investment, and policy support. To sustain strong and durable growth, it must now rebalance more toward ...

This study provides valuable insights into the role of the NF-kB and IKK signaling pathways in γδ T cell development and survival, using robust genetic mouse models. While the research is ...

Lane brought in his only target for a 41-yard gain during Washington's loss to the Lions in Week 10. Lane played just 14 offensive snaps Week 10, his lowest total of the season (tied with Week 3).